UMB Licensee Receives Avon Foundation Grant
Monday, May 6, 2013
UM Ventures congratulates UM Baltimore startup A&G Pharmaceutical on its $300,000 research grant from Avon Foundation. A&G is developing a blood test for use in detection and monitoring of breast cancer using its proprietary biomarker GP88. This grant from the Avon Foundation is the third A&G has received and will enable the company to continue significant progress into the clinical phase of development.